| Primary |
| Computerised Tomogram |
45.4% |
| Scan With Contrast |
10.7% |
| Computerised Tomogram Abdomen |
7.8% |
| Diagnostic Procedure |
3.9% |
| Pain |
3.9% |
| Abdominal Pain |
2.4% |
| Chest Pain |
2.4% |
| Haematuria |
2.4% |
| Neck Pain |
2.4% |
| Urogram |
2.4% |
| Angiogram |
2.0% |
| Catheterisation Cardiac |
2.0% |
| Spinal Myelogram |
2.0% |
| Back Pain |
1.5% |
| Computerised Tomogram Head |
1.5% |
| Coronary Artery Disease |
1.5% |
| Lung Neoplasm Malignant |
1.5% |
| Mass |
1.5% |
| Nodule |
1.5% |
| Ovarian Cancer Stage Iv |
1.5% |
|
| Hypersensitivity |
26.0% |
| Urticaria |
15.2% |
| Anaphylactoid Reaction |
11.3% |
| Anaphylactic Reaction |
5.9% |
| Anaphylactic Shock |
5.9% |
| Vomiting |
4.9% |
| Throat Tightness |
4.4% |
| Contrast Media Reaction |
2.5% |
| Dyspnoea |
2.5% |
| Sneezing |
2.5% |
| Unresponsive To Stimuli |
2.5% |
| Oral Pruritus |
2.0% |
| Pharyngeal Oedema |
2.0% |
| Pruritus |
2.0% |
| Rash |
2.0% |
| Rhabdomyolysis |
2.0% |
| Tachycardia |
2.0% |
| Wheezing |
2.0% |
| Loss Of Consciousness |
1.5% |
| Throat Irritation |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
45.5% |
| Computerised Tomogram |
12.1% |
| Back Pain |
7.6% |
| Ovarian Cancer Stage Iv |
4.5% |
| Pain Management |
4.5% |
| Angiogram |
3.0% |
| Arteriogram Coronary |
3.0% |
| Computerised Tomogram Abdomen |
3.0% |
| Ischaemia |
3.0% |
| Spinal Nerve Stimulator Implantation |
3.0% |
| Chest Pain |
1.5% |
| Coronary Artery Bypass |
1.5% |
| Epidural Test Dose |
1.5% |
| Haematuria |
1.5% |
| Neck Pain |
1.5% |
| Percutaneous Coronary Intervention |
1.5% |
| Williams Syndrome |
1.5% |
|
| Grand Mal Convulsion |
7.7% |
| Nephropathy Toxic |
7.7% |
| Pain In Extremity |
7.7% |
| Pharyngeal Oedema |
7.7% |
| Rhabdomyolysis |
7.7% |
| Tachycardia |
7.7% |
| Brain Oedema |
3.8% |
| Disability |
3.8% |
| Drug Administration Error |
3.8% |
| Dyspnoea |
3.8% |
| Hypersensitivity |
3.8% |
| Hypersomnia |
3.8% |
| Peritonitis |
3.8% |
| Pulmonary Embolism |
3.8% |
| Red Blood Cells Csf Positive |
3.8% |
| Tryptase Increased |
3.8% |
| Urinary Incontinence |
3.8% |
| Urticaria |
3.8% |
| Vasodilatation |
3.8% |
| Ventricular Fibrillation |
3.8% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
30.0% |
| Angiogram |
7.1% |
| Catheterisation Cardiac |
7.1% |
| Coronary Artery Bypass |
7.1% |
| Anaemia |
4.3% |
| Infection |
4.3% |
| Neck Pain |
4.3% |
| X-ray |
4.3% |
| Analgesic Effect |
2.9% |
| Arthritis |
2.9% |
| Computerised Tomogram |
2.9% |
| Computerised Tomogram Abdomen |
2.9% |
| Dyspepsia |
2.9% |
| Dysuria |
2.9% |
| Mitral Valve Repair |
2.9% |
| Pain |
2.9% |
| Renal Cell Carcinoma |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Aortic Surgery |
1.4% |
| Arterectomy With Graft Replacement |
1.4% |
|
| Nephrogenic Systemic Fibrosis |
14.8% |
| Anhedonia |
7.4% |
| Therapeutic Product Contamination |
7.4% |
| Urinary Tract Infection |
7.4% |
| Urticaria |
7.4% |
| Fear Of Death |
3.7% |
| Hypersensitivity |
3.7% |
| Injury |
3.7% |
| Loss Of Consciousness |
3.7% |
| No Therapeutic Response |
3.7% |
| Quality Of Life Decreased |
3.7% |
| Renal Impairment |
3.7% |
| Skin Disorder |
3.7% |
| Skin Induration |
3.7% |
| Skin Tightness |
3.7% |
| Spinal Cord Infarction |
3.7% |
| Stress |
3.7% |
| Surgery |
3.7% |
| Thrombosis In Device |
3.7% |
| Unevaluable Event |
3.7% |
|
